Minerva Neurosciences NERV
NASDAQ NERV
$3.23 +0.00 (+0.00%)
As of: Oct 2, 2026 · 12:51 PM EDT

Minerva Neurosciences (NERV) Accumulated Expenses (2013 - 2014)

Updated

Minerva Neurosciences (NERV) reported Accumulated Expenses of $2.34 million for Q2 2014.

Analysis

Minerva Neurosciences (NERV) Accumulated Expenses (2013 - 2014) Analysis & Trends

At the end of FY2013, Minerva Neurosciences posted Accumulated Expenses of $815,239.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Minerva Neurosciences 158.21 Mn 158.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 2.34 Mn
Dec 31, 2013 815,239.00
API Access

Minerva Neurosciences Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NERV&period=max&api_key=YOUR_API_KEY